Sun Pharma’s Dilip Shanghvi and Uday Kotak re-entered the list this year, replacing Kumar Mangalam Birla of Aditya Birla Group and Jay Chaudhary of Zscaler, according to the study based on estimates till August 30, 2022.
Sandip Sabharwal optimistic on auto stocks despite challenges in two-wheeler demand
The acquisition also seems to be reasonably priced. So, it will only add value to the company because the acquiree SML ISUZU has a good